{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:58:12Z","timestamp":1777057092874,"version":"3.51.4"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Edmund J Safra Foundation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0180733","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T17:35:44Z","timestamp":1500917744000},"page":"e0180733","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson\u2019s disease"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4436-735X","authenticated-orcid":true,"given":"Michel","family":"Modo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Crum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline","family":"Gerwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony C.","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud M.","family":"Iravani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1602\/neurorx.1.1.139","article-title":"Neurodegeneration and neuroprotection in Parkinson disease","volume":"1","author":"S Fahn","year":"2004","journal-title":"NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2003.tb07459.x","article-title":"Physiology and pathophysiology of Parkinson's disease","volume":"991","author":"C Hamani","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13195-014-0073-2","article-title":"Alpha-synuclein biology in Lewy body diseases","volume":"6","author":"WS Kim","year":"2014","journal-title":"Alzheimer's research & therapy"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40478-015-0198-y","article-title":"Neuron-to-neuron alpha-synuclein propagation in vivo is independent of neuronal injury","volume":"3","author":"A Ulusoy","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"ref5","first-page":"4","article-title":"Network structure of brain atrophy in de novo Parkinson's disease","author":"Y Zeighami","year":"2015","journal-title":"Elife"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"KR Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/14737175.2016.1135056","article-title":"The role of biomarkers and imaging in Parkinson's disease","volume":"16","author":"MA Algarni","year":"2016","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis","volume":"86","author":"G Rizzo","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainresrev.2010.05.006","article-title":"Neuroimaging for Lewy body disease: is the in vivo molecular imaging of alpha-synuclein neuropathology required and feasible?","volume":"65","author":"AC Vernon","year":"2010","journal-title":"Brain Res Rev"},{"issue":"16","key":"ref10","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1111\/bph.13208","article-title":"Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors","volume":"172","author":"IF Harrison","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.26968","article-title":"The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward","volume":"32","author":"S Lehericy","year":"2017","journal-title":"Mov Disord"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fneur.2014.00095","article-title":"Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies","volume":"5","author":"CJ Finlay","year":"2014","journal-title":"Front Neurol"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","article-title":"Biomarkers in Parkinson's disease (recent update)","volume":"63","author":"S Sharma","year":"2013","journal-title":"Neurochem Int"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nicl.2013.10.006","article-title":"Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis","volume":"3","author":"ST Schwarz","year":"2013","journal-title":"Neuroimage Clin"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1093\/brain\/awq212","article-title":"Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature","volume":"133","author":"P Peran","year":"2010","journal-title":"Brain"},{"issue":"Pt 10","key":"ref16","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/brain\/awn195","article-title":"Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease","volume":"131","author":"G Rizzo","year":"2008","journal-title":"Brain"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"e114167","DOI":"10.1371\/journal.pone.0114167","article-title":"Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy","volume":"9","author":"A Worker","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"e112638","DOI":"10.1371\/journal.pone.0112638","article-title":"Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study","volume":"9","author":"A Worker","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"e57904","DOI":"10.1371\/journal.pone.0057904","article-title":"Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up","volume":"8","author":"M Ulla","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/mds.24018","article-title":"Do levodopa treatments modify the morphology of the parkinsonian brain?","volume":"27","author":"AC Vernon","year":"2012","journal-title":"Mov Disord"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11910-015-0571-z","article-title":"How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease?","volume":"15","author":"D Bannon","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.expneurol.2004.12.016","article-title":"6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging","volume":"192","author":"T Kondoh","year":"2005","journal-title":"Exp Neurol"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1111\/ejn.13044","article-title":"Magnetic resonance imaging as a tool to image neuroinflammation in a rat model of Parkinson's disease\u2014phagocyte influx to the brain is promoted by bilberry-enriched diet","volume":"42","author":"A Virel","year":"2015","journal-title":"Eur J Neurosci"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"e56501","DOI":"10.1371\/journal.pone.0056501","article-title":"Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study","volume":"8","author":"S Delli Pizzi","year":"2013","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-11-1","article-title":"Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease","volume":"11","author":"AC Vernon","year":"2010","journal-title":"BMC Neurosci"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"e112941","DOI":"10.1371\/journal.pone.0112941","article-title":"Magnetic resonance imaging (MRI) to study striatal iron accumulation in a rat model of Parkinson's disease","volume":"9","author":"A Virel","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"e17269","DOI":"10.1371\/journal.pone.0017269","article-title":"Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's disease","volume":"6","author":"AC Vernon","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/j.1460-9568.2005.04035.x","article-title":"Reduced basal activity and increased functional homogeneity in sensorimotor and striatum of a Parkinson's disease rat model: a functional MRI study","volume":"21","author":"G Pelled","year":"2005","journal-title":"Eur J Neurosci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuroscience.2016.07.046","article-title":"Characterization of gray matter atrophy following 6-hydroxydopamine lesion of the nigrostriatal system","volume":"334","author":"R Westphal","year":"2016","journal-title":"Neuroscience"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.brainresbull.2005.08.005","article-title":"Marmoset monkey models of Parkinson's disease: which model, when and why?","volume":"68","author":"A Eslamboli","year":"2005","journal-title":"Brain research bulletin"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","article-title":"Dopamine neuron systems in the brain: an update","volume":"30","author":"A Bjorklund","year":"2007","journal-title":"Trends in neurosciences"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"a009308","DOI":"10.1101\/cshperspect.a009308","article-title":"Modeling Parkinson's disease in primates: The MPTP model","volume":"2","author":"G Porras","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"ref33","first-page":"364","article-title":"Reproduction in captive common marmosets (Callithrix jacchus)","volume":"53","author":"SD Tardif","year":"2003","journal-title":"Comparative medicine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"845618","DOI":"10.1155\/2012\/845618","article-title":"Classic and new animal models of Parkinson's disease","volume":"2012","author":"J Blesa","year":"2012","journal-title":"Journal of biomedicine & biotechnology"},{"issue":"Suppl 4","key":"ref35","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1353-8020(09)70829-6","article-title":"From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease","volume":"15","author":"P Jenner","year":"2009","journal-title":"Parkinsonism & related disorders"},{"issue":"23\u201324","key":"ref36","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.drudis.2010.08.009","article-title":"The MPTP marmoset model of parkinsonism: a multi-purpose non-human primate model for neurodegenerative diseases","volume":"15","author":"IH Philippens","year":"2010","journal-title":"Drug discovery today"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","article-title":"Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease","volume":"100","author":"D Kirik","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neures.2014.08.014","article-title":"Brain-mapping projects using the common marmoset","volume":"93","author":"H Okano","year":"2015","journal-title":"Neurosci Res"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neures.2009.02.003","article-title":"Web-accessible digital brain atlas of the common marmoset (Callithrix jacchus)","volume":"64","author":"H Tokuno","year":"2009","journal-title":"Neurosci Res"},{"issue":"9","key":"ref40","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/sj.npp.1301329","article-title":"Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging","volume":"32","author":"M Delfino","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.neuroimage.2006.07.004","article-title":"Assessing nigrostriatal dysfunctions by pharmacological MRI in parkinsonian rhesus macaques","volume":"33","author":"Z Zhang","year":"2006","journal-title":"Neuroimage"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brainres.2007.10.059","article-title":"Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy","volume":"1189","author":"SA van Vliet","year":"2008","journal-title":"Brain Res"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1148\/radiol.14140601","article-title":"Parkinson Disease: Diffusion MR Imaging to Detect Nigrostriatal Pathway Loss in a Marmoset Model Treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"275","author":"K Hikishima","year":"2015","journal-title":"Radiology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.neuroscience.2015.05.041","article-title":"Voxel-based morphometry of the marmoset brain: In vivo detection of volume loss in the substantia nigra of the MPTP-treated Parkinson's disease model","volume":"300","author":"K Hikishima","year":"2015","journal-title":"Neuroscience"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2008.01.019","article-title":"Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets","volume":"211","author":"KA Stockwell","year":"2008","journal-title":"Exp Neurol"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1460-9568.2005.03915.x","article-title":"A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets","volume":"21","author":"MM Iravani","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5625\/lar.2015.31.4.155","article-title":"Modeling Parkinson's disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal care","volume":"31","author":"JW Yun","year":"2015","journal-title":"Lab Anim Res"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1471-4159.2005.03625.x","article-title":"Pramipexole protects against MPTP toxicity in non-human primates","volume":"96","author":"MM Iravani","year":"2006","journal-title":"J Neurochem"},{"key":"ref49","article-title":"The marmoset brain in stereotaxic coordinates","author":"X Palazzi","year":"2008"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jneumeth.2013.05.009","article-title":"A comparison of automated anatomical-behavioural mapping methods in a rodent model of stroke","volume":"218","author":"WR Crum","year":"2013","journal-title":"J Neurosci Methods"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneumeth.2013.03.015","article-title":"Registration of challenging pre-clinical brain images","volume":"216","author":"WR Crum","year":"2013","journal-title":"J Neurosci Methods"},{"issue":"21","key":"ref52","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1088\/0031-9155\/50\/21\/014","article-title":"Anisotropic multi-scale fluid registration: evaluation in magnetic resonance breast imaging","volume":"50","author":"WR Crum","year":"2005","journal-title":"Phys Med Biol"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1006\/nimg.2001.1037","article-title":"Thresholding of statistical maps in functional neuroimaging using the false discovery rate","volume":"15","author":"CR Genovese","year":"2002","journal-title":"Neuroimage"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1471-4159.2009.05956.x","article-title":"An immunohistochemical and stereological analysis of PSI-induced nigral neuronal degeneration in the rat","volume":"109","author":"S Bukhatwa","year":"2009","journal-title":"J Neurochem"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3233\/JPD-160824","article-title":"Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression","volume":"6","author":"NW Sterling","year":"2016","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jamaneurol.2013.597","article-title":"Substantia nigra volume loss before basal forebrain degeneration in early Parkinson disease","volume":"70","author":"DA Ziegler","year":"2013","journal-title":"JAMA Neurol"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410350609","article-title":"MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys","volume":"35","author":"RS Miletich","year":"1994","journal-title":"Ann Neurol"},{"issue":"7","key":"ref58","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2012.09.029","article-title":"Lithium, gray matter, and magnetic resonance imaging signal","volume":"73","author":"DA Cousins","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"8","key":"ref59","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1460-9568.2011.07639.x","article-title":"In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson's disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-hydroxydopamine rat model","volume":"33","author":"G Soria","year":"2011","journal-title":"Eur J Neurosci"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00429-013-0669-5","article-title":"An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease","volume":"220","author":"IS Pienaar","year":"2015","journal-title":"Brain Struct Funct"},{"issue":"12","key":"ref61","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3174\/ajnr.A4055","article-title":"Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis","volume":"35","author":"E Mak","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mds.24938","article-title":"Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia","volume":"27","author":"JG Goldman","year":"2012","journal-title":"Mov Disord"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"e54980","DOI":"10.1371\/journal.pone.0054980","article-title":"Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease","volume":"8","author":"J Pagonabarraga","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"ref64","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.parkreldis.2015.05.013","article-title":"Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease","volume":"21","author":"E Mak","year":"2015","journal-title":"Parkinsonism & related disorders"},{"issue":"7","key":"ref65","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/nbm.1381","article-title":"Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract","volume":"22","author":"N Van Camp","year":"2009","journal-title":"NMR Biomed"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/ene.12838","article-title":"Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease","volume":"23","author":"S Reimao","year":"2016","journal-title":"Eur J Neurol"},{"issue":"9","key":"ref67","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/sj.npp.1300710","article-title":"The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys","volume":"30","author":"KA Dorph-Petersen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fninf.2012.00006","article-title":"Wanted dead or alive? The tradeoff between in-vivo versus ex-vivo MR brain imaging in the mouse","volume":"6","author":"JP Lerch","year":"2012","journal-title":"Front Neuroinform"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0180733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:56:17Z","timestamp":1588964177000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0180733"}},"subtitle":[],"editor":[{"given":"Richard Jay","family":"Smeyne","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":68,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0180733","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]}}}